Celladon Announces Commencement of Public Offering of Common Stock
August 07, 2014 06:30 ET
|
Celladon Corporation
SAN DIEGO, Aug. 7, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Corporation Secures $25 Million Credit Facility From Hercules Growth Capital
August 01, 2014 07:00 ET
|
Celladon Corporation
SAN DIEGO, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon to Report Second Quarter 2014 Results on August 7, 2014
July 30, 2014 16:15 ET
|
Celladon Corporation
SAN DIEGO, July 30, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Corporation Announces In-License of Stem Cell Factor Development Program
July 21, 2014 07:00 ET
|
Celladon Corporation
SAN DIEGO, July 21, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium...
Celladon Corporation Announces New Clinical Development Initiatives for MYDICAR(R)
July 07, 2014 07:00 ET
|
Celladon Corporation
SAN DIEGO, July 7, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...
Celladon Corporation Appoints Elizabeth E. Reed General Counsel
June 09, 2014 07:01 ET
|
Celladon Corporation
SAN DIEGO, June 9, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...
Celladon Corporation Appoints Industry Veteran Paul Cleveland as President and Chief Financial Officer
June 02, 2014 07:00 ET
|
Celladon Corporation
SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...
Celladon to Present at the Jefferies 2014 Global Healthcare Conference
May 27, 2014 16:15 ET
|
Celladon Corporation
SAN DIEGO, May 27, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...
Celladon Reports First Quarter 2014 Financial Results and Recent Highlights
May 13, 2014 16:05 ET
|
Celladon Corporation
SAN DIEGO, May 13, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the...
Celladon to Report First Quarter 2014 Results on May 13, 2014
May 06, 2014 06:30 ET
|
Celladon Corporation
SAN DIEGO, May 6, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases...